TFX Stock Summary and Trading Ideas (Teleflex | NYSE:TFX)

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Teleflex trades on the NYSE stock market under the symbol TFX.

As of March 3, 2025, TFX stock price climbed to $135.13 with 1,995,839 million shares trading.

TFX has a beta of 0.28, meaning it tends to be less sensitive to market movements. TFX has a correlation of 0.01 to the broad based SPY ETF.

TFX has a market cap of $6.27 billion. This is considered a Mid Cap stock.

Last quarter Teleflex reported $795 million in Revenue and $3.89 earnings per share. This fell short of revenue expectation by $-18 million and exceeded earnings estimates by $.01.

In the last 3 years, TFX traded as high as $356.72 and as low as $128.55.

The top ETF exchange traded funds that TFX belongs to (by Net Assets): VTI, VOO, VB, VBR, RSP.

TFX has underperformed the market in the last year with a price return of -39.2% while the SPY ETF gained +16.7%. TFX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -29.6% and -19.3%, respectively, while the SPY returned -2.2% and -4.3%, respectively.

TFX support price is $130.76 and resistance is $134.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TFX shares will trade within this expected range on the day.